Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

AbbVie Inc (NYSE:ABBV)

65.84
Delayed Data
As of May 23
 0.00 / 0.00%
Today’s Change
55.06
Today|||52-Week Range
68.12
+5.14%
Year-to-Date
Wall Street Weighs In on Athenahealth's Strategic Options
May 19 / TheStreet.com - Paid Partner Content
AbbVie Down on Humira Patent Loss: Is More Damage in Store?
May 18 / Zacks.com - Paid Partner Content
What Drug Approval Means for Neurocrine Biosciences
May 19 / GuruFocus News - Paid Partner Content
AbbVie Stock Lower on Humira Patent Ruling
May 17 / TheStreet.com - Paid Partner Content
The Zacks Analyst Blog Highlights: Boeing, AbbVie, UnitedHealth, Consolidated Edison ...
May 19 / Zacks.com - Paid Partner Content
Celgene's (CELG) Revlimid Looks Solid on Label Expansion
May 16 / Zacks.com - Paid Partner Content
AbbVie's Humira Loses Patent in Coherus' Petitions
May 18 / GuruFocus News - Paid Partner Content
AbbVie and J&J Present Positive Imbruvica Leukemia Data
May 15 / Zacks.com - Paid Partner Content
New Stock Research Reports for Boeing, AbbVie and UnitedHealth
May 18 / Zacks.com - Paid Partner Content
Infinity (INFI) Reports Narrower-than-Expected Loss in Q1
May 10 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close65.84
Today’s openn.a.
Day’s range-- - --
Volume227,743
Average volume (3 months)6,341,096
Market cap$104.4B
Dividend yield3.89%
Data as of 05/23/2017

Growth & Valuation

Earnings growth (last year)+15.97%
Earnings growth (this year)+14.70%
Earnings growth (next 5 years)+12.00%
Revenue growth (last year)+12.16%
P/E ratio17.1
Price/Sales3.98
Price/Book22.53

Competitors

 Today’s
change
Today’s
% change
GSKGlaxoSmithKline-0.34-0.79%
CELGCelgene+1.60+1.38%
BMYBristol-Myers Squibb0.000.00%
LLYEli Lilly and Co0.000.00%
Data as of 4:14pm ET, 05/23/2017

Financials

Next reporting dateJuly 28, 2017
EPS forecast (this quarter)$1.39
Annual revenue (last year)$25.6B
Annual profit (last year)$5.9B
Net profit margin23.10%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chairman &
Chief Executive Officer
Richard A. Gonzalez
Senior Vice President-
Operations
Azita Saleki-Gerhardt
Corporate headquarters
North Chicago, Illinois

Forecasts